Myrtle (Myrtus communis L.) fruit syrup for gastroesophageal reflux disease in children: A double-blind randomized

Maryam Sadat Paknejad1, Kambiz Eftekhari2, Roja Rahimi1

  • 1School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Phytotherapy Research : PTR
|September 17, 2021
PubMed

Insights

Myrtle fruit syrup showed no significant difference in GERD scores for children, but may help with low appetite. Further research is needed for conclusive results on gastroesophageal reflux disease treatment.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Pharmacology

Background:

  • Gastroesophageal reflux disease (GERD) is common in children.
  • Current treatments for pediatric GERD have limitations.
  • Natural remedies are being explored for GERD management.

Purpose of the Study:

  • To evaluate the efficacy of Myrtus communis L. (myrtle) fruit syrup as an adjunct treatment for pediatric GERD.
  • To compare the effects of myrtle fruit syrup versus placebo in children with GERD.

Main Methods:

  • A double-blind, randomized controlled trial was conducted.
  • Children aged 1-7 years with GERD received either omeprazole with myrtle fruit syrup or omeprazole with placebo syrup.
  • The GERD Symptom Questionnaire for Young Children (GSQ-YC) was used to assess symptoms at baseline, 8 weeks, and 4 weeks post-intervention.

Main Results:

  • No statistically significant differences in overall GERD scores were observed between the myrtle syrup and placebo groups at 8 or 12 weeks.
  • The myrtle group showed a statistically significant reduction in "refusal to eat" symptom compared to the placebo group at 8 weeks (p=0.018) and study end (p=0.042).
  • While not statistically significant, the myrtle group had a smaller increase in GERD scores after treatment cessation compared to the placebo group.

Conclusions:

  • Myrtle fruit syrup may not be effective for overall GERD symptom management in children.
  • Myrtle fruit syrup shows potential benefits for improving appetite in children with GERD.
  • Further clinical trials are warranted to confirm these findings and explore optimal usage.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
256
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
825
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
669
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
377
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
190
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
571